Klaus Okkenhaug
- Molecular Biology top 0.5%
- Immunology top 0.1%
- Oncology top 0.5%
- Genetics top 0.2%
- Cancer Research top 0.5%
- Co-authors
- Bart VanhaesebroeckMichael D. WaterfieldMartin TurnerAntonio BilancioDalya R. SoondWayne PearceS. L. WhiteRoy Katso
- Topics
- Immune Cell Function and Interaction (55 papers)T-cell and B-cell Immunology (53 papers)PI3K/AKT/mTOR signaling in cancer (28 papers)
- Cited by
- ImmunologyGeneticsAging
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Klaus Okkenhaug
119 papers receiving 14.2k citations
Hit Papers
Peers
Comparison fields: 5 of 171
- Molecular Biology 7.0k
- Immunology 6.7k
- Oncology 3.1k
- Genetics 2.4k
- Cancer Research 2.2k
Countries citing papers authored by Klaus Okkenhaug
This map shows the geographic impact of Klaus Okkenhaug's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Okkenhaug with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Okkenhaug more than expected).
Fields of papers citing papers by Klaus Okkenhaug
This network shows the impact of papers produced by Klaus Okkenhaug. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Okkenhaug. The network helps show where Klaus Okkenhaug may publish in the future.
Co-authorship network of co-authors of Klaus Okkenhaug
This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Okkenhaug. A scholar is included among the top collaborators of Klaus Okkenhaug based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Okkenhaug. Klaus Okkenhaug is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 35 | |
| 4 | 11 | |
| 5 | 15 | |
| 6 | 16 | |
| 7 | 265 | |
| 8 | 65 | |
| 9 | 調節性T細胞移動はグルコキナーゼ仲介される解糖に依存している【Powered by NICT】 | 49 |
| 10 | 57 | |
| 11 | Cross-talk between PI3-kinase and cAMP-Protein Kinase signaling pathways at the level of a Protein Kinase B / -arrestin / cAMP phosphodiesterase-4 complex | 8 |
| 12 | 293 | |
| 13 | Requirement of bic/microRNA-155 for Normal Immune Functionbreakdown → | 1561 |
| 14 | Physiological and aberrant regulation of memory T cell trafficking by the co-stimulatory molecule CD28 | 2 |
| 15 | 70 | |
| 16 | 175 | |
| 17 | 40 | |
| 18 | 118 | |
| 19 | Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Micebreakdown → | 761 |
| 20 | 179 |
About Klaus Okkenhaug
Klaus Okkenhaug is a scholar working on Immunology, Genetics and Oncology, having authored 119 papers that have together received 14.4k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (55 papers), T-cell and B-cell Immunology (53 papers) and PI3K/AKT/mTOR signaling in cancer (28 papers). The work is most often cited by research in Immunology (6.7k citations), Genetics (2.4k citations) and Aging (311 citations). Klaus Okkenhaug has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Bart Vanhaesebroeck, Michael D. Waterfield, Martin Turner, Antonio Bilancio, Dalya R. Soond, Wayne Pearce, S. L. White, Roy Katso, John F. Timms and Khatereh Ahmadi. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.